Bleomycin is a glycopeptide used as a chemotherapeutic agent for lymphomas, germ cell tumors, and pleurodesis of malignant pleural effusions. The pulmonary toxicity of bleomycin is well known while the cutaneous side effects are uncommon and varies from generalized hyperpigmentation, sclerodermoid changes, erythema multiformae, and gangrene to flagellate dermatosis. Here we report a characteristic but rare side effect of flagellate erythema, which developed secondary to bleomycin in a 27-year old woman with Hodgkin’s lymphoma after two cycles of treatment with adriamycin, bleomycin, vinblastine, dacarbazine regimen. The rash subsided after discontinuation of bleomycin and treatment with steroids.
ReinertTBaldottoCSdRNunesFAP. Bleomycin-induced lung injury. J Cancer Res2013. 9 ppdoi:10.1155/2013/480608.
5.
ZiemerMGoetzeSJuhaszK. Flagellate dermatitis as a bleomycin-specific adverse effect of cytostatic therapy: a clinical-histopathologic correlation. Am J Clin Dermatol2011; 12: 68–76.
6.
BiswasAChaudhariPBSharmaP. Bleomycin induced flagellate erythema: revisiting a unique complication. J Cancer Res Ther2013; 9: 500–503.
7.
LazoJSHumphreysCJ. Lack of metabolism as the biochemical basis of bleomycin-induced pulmonary toxicity. Proc Natl Acad Sci U S A1983; 80: 3064–3068.
8.
FyfeAJMcKayP. Toxicities associated with bleomycin. J R Coll Physicians Edinb2010; 40: 213–215.
9.
CortinaPGarridoJATomasJF. ‘Flagellate’ erythema from bleomycin. With histopathological findings suggestive of inflammatory oncotaxis. Dermatologica1990; 180: 106–109.
Fernandez-ObregonACHoganKPBibroMK. Flagellate pigmentation from intrapleural bleomycin. A light microscopy and electron microscopy study. J Am Acad Dermatol1985; 13: 464–468.
12.
AbessAKeelDMGrahamBS. Flagellate hyperpigmentation following intralesional bleomycin treatment of verruca plantaris. Arch Dermatol2003; 139: 337–339.
13.
ManojJKaliyadanFDharmaratnamAD. Palmar and flagellate hyperpigmentation following low dose intralesional injection of bleomycin for cystic hygroma. Dermatol Online J2008; 14: 19–19.
14.
TodkillDTaibjeeSBorgA. Flagellate erythema due to bleomycin. Br J Haematol2008; 142: 857–857.
15.
PoppeLMAndersDKneitzH. Flagellate dermatitis caused by shiitake mushrooms. Anais Brasileiros de Dermatologia2012; 87: 463–465.
16.
CilibertoHKumarMGMusiekA. Flagellate erythema in a patient with fever. JAMA Dermatol2013; 149: 1425–1426.
17.
NousariHHaVLamanS. “Centripetal flagellate erythema”: a cutaneous manifestation associated with dermatomyositis. J Rheumatol1999; 26: 692–695.
18.
JaraMAmerigoJDuceS. Dermatomyositis and flagellate erythema. Clin Exp Dermatol1996; 21: 440–441.
SikicBICollinsJMMimnaughEG. Improved therapeutic index of bleomycin when administered by continuous infusion in mice. Cancer Treat Rep1978; 62: 2011–2017.
23.
PengYMAlbertsDSChenHS. Antitumour activity and plasma kinetics of bleomycin by continuous and intermittent administration. Br J Cancer1980; 41: 644–647.
24.
CarlsonRWSikicBI. Continuous infusion or bolus injection in cancer chemotherapy. Ann Intern Med1983; 99: 823–833.
25.
CooperKRHongWK. Prospective study of the pulmonary toxicity of continuously infused bleomycin. Cancer Treat Rep1981; 65: 419–425.
26.
CanellosGPDugganDJohnsonJ. How important is bleomycin in the adriamycin + bleomycin + vinblastine + dacarbazine regimen?J Clin Oncol2004; 22: 1532–1533.
27.
MartinWGRistowKMHabermannTM. Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin's lymphoma. J Clin Oncol2005; 23: 7614–7620.
28.
BehringerKGoergenHHitzF. Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial. Lancet2014. Epub 30 December 2014, doi: 10.1016/s0140-6736(14)61469-0.
